Get the Stockscreener App
3.57
1.13%
0.04
After Hours:
3.53
-0.04
-1.12%
Aclarion Inc stock is traded at $3.57, with a volume of 74,609.
It is up +1.13% in the last 24 hours and up +11.56% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$3.53
Open:
$3.49
24h Volume:
74,609
Relative Volume:
0.76
Market Cap:
$8.79M
Revenue:
$75,700
Net Income/Loss:
$-7.23M
P/E Ratio:
-0.2075
EPS:
-17.2081
Net Cash Flow:
$-7.37M
1W Performance:
+8.84%
1M Performance:
+11.56%
6M Performance:
-41.86%
1Y Performance:
-47.14%
1-Day Range:
$3.42
$3.59
1-Week Range:
$3.28
$3.6121
52-Week Range:
$2.3401
$12.03
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
3.57 | 8.69M | 75,700 | -7.23M | -7.37M | -17.21 |
VEEV
Veeva Systems Inc
|
172.61 | 29.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
57.40 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.43 | 9.38B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.67 | 7.19B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
63.62 | 4.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc Stock (ACON) Latest News
Aclarion, Inc. 8-K SEC Filing June 2026 – Equity Incentive Plan Amendment Approved and Company Information - Minichart
Aclarion Stockholders Approve Directors and Equity Plan Amendment - TipRanks
Aclarion (ACON) shareholders elect board, ratify auditor and approve equity plan - Stock Titan
Aclarion partners with Los Angeles neuroscience clinic for study By Investing.com - Investing.com Australia
Aclarion partners with Los Angeles neuroscience clinic for study - Investing.com
Aclarion Expands Nociscan Availability in Greater Los Angeles Through Partnership with Institute of Neuro Innovation - Quiver Quantitative
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation - marketscreener.com
Back-pain scan Nociscan helps pinpoint bad discs, now in L.A. - Stock Titan
Aclarion's Nociscan tech reveals immune-linked back pain subtypes, expanding precision spine care potential. - Pluang
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study - The Manila Times
Aclarion's Nociscan Technology Linked to Immune Signatures in Back Pain Study, Expanding Clinical Applications - Quiver Quantitative
Aclarion’s Nociscan technology used in back pain study - Investing.com
Study links immune signatures to back pain using Aclarion scan tech - Stock Titan
ACON Maintained by Ascendiant Capital -- Price Target Raised to $7.50 - GuruFocus
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For Friday - Benzinga
Aclarion Inc. Warrants (ACONW) Edge Lower as Tight Trading Range Persists at $0.03Algorithmic Stock Picks - The Legal Advocate
Aclarion: Board Will Determine Course of Action It Believes Is in Best Interests of Co, Hldrs >ACON - Moomoo
Aclarion to Review Echo Lake Capital’s Unsolicited Proposal - geneonline.com
Aclarion: Echo Lake Communication Contains Numerous Assertions Regarding Governance and Other Matters That Lack Important Context >ACON - Moomoo
Aclarion: Echo Lake Cap Offered to Acquire the Co for $4/Shr in Cash and Contingent Value Rights >ACON - Moomoo
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal - The Manila Times
Aclarion, Inc. Responds to Echo Lake Capital's Acquisition Proposal and Reaffirms Commitment to Shareholder Value - Quiver Quantitative
Aclarion says board to review Echo Lake Capital's acquisition proposal - marketscreener.com
Aclarion Says Board To Review Echo Lake Capital's Acquisition Proposal - TradingView
Echo Lake Capital Pressures Aclarion Board With Buyout Proposal and Reverse Merger Push - citybiz
Echo Lake Capital Offers To Acquire Aclarion Inc. - marketscreener.com
Echo Lake Capital proposed to acquire Aclarion, Inc.. - marketscreener.com
ACON News | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Inc. (ACON) Slips 1.56% as Shares Approach Key Support at $3.0Hedge Fund Exposure - The Legal Advocate
Aclarion Inc. (ACON) Tests Support Zone After 1.56% DeclineAdaptive Moving Average - The Legal Advocate
Aclarion Inc. (ACON) Slips 1.8% Amid Low Volume: Support at $3.05 Holds the KeyNHNL Divergence - The Legal Advocate
Aclarion Inc. Warrant (ACONW) Declines Sharply, Testing All-Time Low TerritoryBreadth Thrust - Newser
Aclarion Inc. Q1 2026 Earnings: EPS Surpasses Estimates as Company Prioritizes Cost ControlsStock Idea Network - Newser
Aclarion (ACON) upgraded to buy: Here's why - MSN
ACON Stock Price, Quote & Chart | ACLARION INC (NASDAQ:ACON) - ChartMill
Aclarion Q1 2026 Earnings: EPS Surpasses Estimates by 15.2%, Pre-Revenue Stage ContinuesEnergy Earnings Report - Newser
ACONW SEC FilingsACLARION INC 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion (ACON) Q1 2026 Earnings: $-1.34 EPS Surges Past $-1.58 EstimatesCommunity Watchlist Picks - Newser
Aclarion (ACON) Upgraded to Buy: Here's Why - Yahoo Finance
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com - Investing.com Nigeria
Why Is Aclarion, Inc. (ACONW) Stock Down Today? - Meyka
Aclarion announces $2.5M stock repurchase plan - MSN
Aclarion (ACON) Crushes Q1 2026 Estimates — EPS $-1.34 Tops ViewsExpert Entry Points - Newser
Aclarion, Inc. (ACON) reports Q1 loss, misses revenue estimates - MSN
Aclarion sees net loss but strengthens cash position - BizWest
ACON SEC FilingsAclarion Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Aclarion, Inc. 1Q 2026: Revenue $21.1K, EPS $(1.34) — 10-Q Summary - TradingView
Aclarion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.46%
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):